USP Will Release Information Chapters On Follow-On Biologics Starting In ’05
United States Pharmacopoeia will publish information chapters on determining equivalence between follow-on and source biologics starting in 2005
You may also be interested in...
Published monographs for biologics could hinder the development of follow-on products, United States Pharmacopeia CEO Roger Williams, MD, said
FDA and industry need to work out the science of generic biologics before a legislative debate would be useful, FDA Principle Associate Commissioner Murray Lumpkin, MD, suggested
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011